Article
Use of Density Functional Calculations To Predict the Regioselectivity of Drugs and Molecules Metabolized by Aldehyde Oxidase
To whom correspondence should be addressed. For R.A.T.: phone, 509-335-1516; e-mail, rhonda.torres@yahoo.com. For K.R.K.: e-mail, korzekwa@allchemie.net. For J.P.J.: phone, 509-335-5983; e-mail, jpj@wsu.edu.
Department of Molecular Systems, Merck Research Laboratories.
Washington State University.
Department of Drug Metabolism, Merck Research Laboratories.
Abstract

Aldehyde oxidase is a molybdenum hydroxylase that catalyzes the oxidation of aldehydes and nitrogen-containing heterocycles. The enzyme plays a dual role in the metabolism of physiologically important endogenous compounds and the biotransformation of xenobiotics. Using density functional theory methods, geometry optimization of tetrahedral intermediates of drugs and druglike compounds was examined to predict the likely metabolites of aldehyde oxidase. The calculations suggest that the lowest energy tetrahedral intermediate resulting from the initial substrate corresponds to the observed metabolite ≥90% of the time. Additional calculations were performed on a series of heterocyclic compounds where the products resulting from metabolism by xanthine oxidase and aldehyde oxidase differ in many instances. Again, the lowest energy tetrahedral intermediate corresponded to the observed product of aldehyde oxidase metabolism ≥90% for the compounds examined, while the observed products of xanthine oxidase were not well predicted.
View: Full Text HTML | Hi-Res PDF
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
History
- Published In Issue September 20, 2007
- Received March 28, 2007
Cart


